Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Event detection using population-based health care databases in randomized clinical trials: a novel research tool in interventional cardiologyClinical Epidemiology, 2013
- Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery DiseaseJACC: Cardiovascular Interventions, 2013
- The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantationEuroIntervention, 2012
- Randomized Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents in Patients Treated With Percutaneous Coronary InterventionCirculation, 2012
- 2-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily PracticeJACC, 2011
- Randomized Comparison of Everolimus- and Paclitaxel-Eluting StentsJACC, 2011
- Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting StentsJACC: Cardiovascular Interventions, 2011
- Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary StentsNew England Journal of Medicine, 2010
- Rationale and Design of a Randomized Clinical Comparison of Everolimus-Eluting (Xience V/Promus) and Sirolimus-Eluting (Cypher Select+) Coronary Stents in Unselected Patients with Coronary Heart DiseaseCardiology, 2010
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003